COVID-19 Funding Snapshot for Pharma Developers/Manufacturers

Views as of August 7, 2020

Cassie Guo

Adam-Nover

Pharma Developers/Manufacturers

COVID-19 pharmaceutical funding landscape

COVID-19 funding has predominantly

COVID-19 drug development

U.S. funding is spread across

government vaccine supply deals

Though funding appears

Select funding deals across

US public deals with disclosed

US public deals with disclosed

Ex-US public deals

with disclosed values

Foundation deals with disclosed

Industry deals with disclosed

COVID-19 funding deals disclaimer

Contributing authors:

Tony Stripling, Associate Consultant
Sean Saunders, Life Sciences Speciaist
Jennifer Henry, Associate Consultant
Patrick Marquet, Associate

Related Insights

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 4

April 20, 2020

Italy, Spain and France are now several weeks past peak virus intensity, taking approximately two weeks to reach 50% of peak levels

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 6

May 11, 2020

The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies

Life Sciences & Pharma

Executive Insights

Managing Non-Core Assets: Innovative Funding Models for Biopharma Companies

May 15, 2020

We discuss some of the innovative funding models available and identify the key strategies for optimizing these types of deals.

Life Sciences & Pharma

Special Report

Weighing the Trade-offs of a Direct Presence in Japan’s Rare and Orphan Drug Market

February 20, 2020

In recent years, there has been a marked uptick in the number of rare and orphan companies establishing local operations in Japan to steward their…

Strategy

Presentations

Global Situation Report Insights Edition 1

May 27, 2020

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.

Healthcare Services

Special Report

Changing the Future of Chilean Women

October 26, 2020

In 2018, almost 2.1 million women were diagnosed with breast cancer, and more than 630,000 female patients died from it.